← All organizations
Highest phase reached
Phase 1
First clinical trial
Aug 9, 2021Last known activity
Aug 9, 2021
Timeline
2020s
- Jun 1, 2020
EOM Pharmaceuticals— Founded
- Dec 2, 2021
ImmunoCellular Therapeutics, Ltd.— Acquired
Drugs by trial phase (3 distinct, 4 trials)
Phase 3 (0 own, 1 via acquisition)
Phase 1 (1 own, 1 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (1)
- NCT05212532Lead sponsorPhase 1Aug 9, 2021
Details
- Founded
- Montvale, NJ, US Jun 1, 2020
- Last known activity
- Aug 9, 2021